ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

AHRQ Funds Research To Reduce Medical Errors.

October 19, 2001

Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion

November 3, 1978

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975